Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

23andMe laid off 100 employees due to slowing DNA kit sales

Privacy concerns likely factored into decreased demand.

Photo of a 23andMe testing kit opened up.
Photo of a 23andMe testing kit opened up.
Eric Baradat/AFP via Getty Images
Rani Molla
Rani Molla was a senior correspondent at Vox and has been focusing her reporting on the future of work. She has covered business and technology for more than a decade — often in charts — including at Bloomberg and the Wall Street Journal.

23andMe, the popular DNA testing company, is laying off about 100 employees or 14 percent of its workforce as consumer demand for its kits has weakened. The company said that a variety of factors, including privacy concerns, could have contributed to the slowing market.

“This has been slow and painful for us,” CEO Anne Wojcicki told CNBC, adding that she was “surprised” by the decreased demand for the company’s DNA tests, which tell consumers about their ancestry as well as potential health issues.

Wojcicki said that “privacy is top of mind” for both consumers and the company.

Concerns about DNA test privacy have increased in recent years along with their popularity, as consumers look for ways to protect their personal information even as it becomes more readily available online.

Last month, the Pentagon warned armed forces members not to take consumer DNA tests, saying, “Exposing sensitive genetic information to outside parties poses personal and operational risks to Service members.” Earlier in December, Recode published a story about the variety of privacy issues that consumer DNA tests raise, including how law enforcement, life insurance companies, advertisers, and even international terrorists might wield the data.

The layoffs are concentrated in the consumer DNA test part of the company; employees in the company’s therapeutic drug discovery arm are not affected.

23andMe has sold over 10 million DNA kits, mostly within the US. The company was an early entrant in the consumer DNA testing space but it now has lots of competition, including from companies like Ancestry and FamilyTreeDNA. Additionally, a whole cottage industry has cropped up around DNA test results, offering specious services like pairing people with the best diet or best wine for their genes. The privacy policies surrounding these companies are also untested.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh